These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 8700135

  • 1. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M, Rudolf K, Wittneben H, Herzog H, Martinez R, Munoz M, Eberlein W, Engel W, Walker P, Beck-Sickinger AG.
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [Abstract] [Full Text] [Related]

  • 2. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    Wieland HA, Willim KD, Entzeroth M, Wienen W, Rudolf K, Eberlein W, Engel W, Doods HN.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN, Wienen W, Entzeroth M, Rudolf K, Eberlein W, Engel W, Wieland HA.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE.
    Acta Physiol Scand Suppl; 1997 Oct; 636():1-55. PubMed ID: 9179320
    [Abstract] [Full Text] [Related]

  • 5. Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
    Akerberg H, Fällmar H, Sjödin P, Boukharta L, Gutiérrez-de-Terán H, Lundell I, Mohell N, Larhammar D.
    Regul Pept; 2010 Aug 09; 163(1-3):120-9. PubMed ID: 20471432
    [Abstract] [Full Text] [Related]

  • 6. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
    Jois SD, Nagarajarao LM, Prabhakaran M, Balasubramaniam A.
    J Biomol Struct Dyn; 2006 Apr 09; 23(5):497-508. PubMed ID: 16494499
    [Abstract] [Full Text] [Related]

  • 7. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE, Balmér KC, Lundberg JM.
    Br J Pharmacol; 1997 Jun 09; 121(3):595-603. PubMed ID: 9179405
    [Abstract] [Full Text] [Related]

  • 8. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C, Beck-Sickinger AG.
    J Pept Sci; 2000 Mar 09; 6(3):97-122. PubMed ID: 10759209
    [Abstract] [Full Text] [Related]

  • 9. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
    Schroeder JP, Olive F, Koenig H, Hodge CW.
    Alcohol Clin Exp Res; 2003 Dec 09; 27(12):1884-91. PubMed ID: 14691375
    [Abstract] [Full Text] [Related]

  • 10. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
    Weiss S, Keller M, Bernhardt G, Buschauer A, König B.
    Bioorg Med Chem; 2008 Nov 15; 16(22):9858-66. PubMed ID: 18851917
    [Abstract] [Full Text] [Related]

  • 11. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
    Fällmar H, Åkerberg H, Gutiérrez-de-Terán H, Lundell I, Mohell N, Larhammar D.
    Neuropeptides; 2011 Aug 15; 45(4):293-300. PubMed ID: 21696823
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S, Li DL, Simmons RM.
    J Pharmacol Exp Ther; 1999 May 15; 289(2):1031-40. PubMed ID: 10215684
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptor.
    Vanderheyden PM, Van Liefde I, de Backer JP, Vauquelin G.
    J Recept Signal Transduct Res; 1998 May 15; 18(4-6):363-85. PubMed ID: 9879066
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
    Lindner D, van Dieck J, Merten N, Mörl K, Günther R, Hofmann HJ, Beck-Sickinger AG.
    Biochemistry; 2008 Jun 03; 47(22):5905-14. PubMed ID: 18457425
    [Abstract] [Full Text] [Related]

  • 20. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM, Saar K, Lundell I, Langel U, Larhammar D.
    Neuropeptides; 2001 Jun 03; 35(3-4):148-53. PubMed ID: 11884204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.